Chemical neuroprotection in the cochlea: the modulation of dopamine release from lateral olivocochlear efferents
- PMID: 21672572
- DOI: 10.1016/j.neuint.2011.05.015
Chemical neuroprotection in the cochlea: the modulation of dopamine release from lateral olivocochlear efferents
Abstract
The prevalence of sensorineural hearing loss is increasing worldwide, mainly due to ageing, increased noise exposure and cardiovascular risk factors. Several papers dealt with the mechanisms underlying the primary causes of impaired hearing and eventual deafness, including the damage and loss of auditory hair cells; however, very little is known about the protective mechanisms that exist for hearing. Several recent investigations have implicated dopamine (DA) in a neuroprotective circuit for the cochlea. The lateral olivocochlear (LOC) efferents provide axonal innervation of the inner hair cell afferent synapses and release DA and other substances in response to different stimuli. Under ischemic conditions or during noise exposure, DA has been proven to play a neuroprotective role against glutamate excitotoxicity. This review summarises what is currently known about the modulation of DA release in the cochlea, using primarily in vitro experimental data. Based on recent knowledge, there could be two functional subgroups within the LOC fibres, i.e., the DA- and GABA-containing projections. In this review, we attempt to show the neurochemical interactions between these two subsystems. Other aspects of cochlear neurotransmission are also discussed to provide a complete picture of cochlear dopaminergic function in physiological and pathophysiological cases with particular reference to excitotoxicity.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Cochlear dopamine release is modulated by group II metabotropic glutamate receptors via GABAergic neurotransmission.Neurosci Lett. 2005 Sep 9;385(2):93-8. doi: 10.1016/j.neulet.2005.05.017. Neurosci Lett. 2005. PMID: 15927369
-
The role of N-methyl-D-aspartate receptors and nitric oxide in cochlear dopamine release.Neuroscience. 2008 Jun 23;154(2):796-803. doi: 10.1016/j.neuroscience.2008.03.071. Epub 2008 Apr 7. Neuroscience. 2008. PMID: 18462886
-
D2 autoreceptor inhibition reveals oxygen-glucose deprivation-induced release of dopamine in guinea-pig cochlea.Neuroscience. 2005;132(3):801-9. doi: 10.1016/j.neuroscience.2005.01.023. Neuroscience. 2005. PMID: 15837140
-
Environmental enrichment to sound activates dopaminergic pathways in the auditory system.Physiol Behav. 2007 Sep 10;92(1-2):34-9. doi: 10.1016/j.physbeh.2007.05.020. Epub 2007 May 21. Physiol Behav. 2007. PMID: 17631367 Review.
-
Chemical synaptic transmission in the cochlea.Prog Neurobiol. 1995 Dec;47(6):449-76. doi: 10.1016/0301-0082(95)00028-3. Prog Neurobiol. 1995. PMID: 8787031 Review.
Cited by
-
Diverse identities and sites of action of cochlear neurotransmitters.Hear Res. 2022 Jun;419:108278. doi: 10.1016/j.heares.2021.108278. Epub 2021 May 24. Hear Res. 2022. PMID: 34108087 Free PMC article. Review.
-
The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model.Elife. 2020 Jul 28;9:e56235. doi: 10.7554/eLife.56235. Elife. 2020. PMID: 32720645 Free PMC article.
-
'Ecstasy' enhances noise-induced hearing loss.Hear Res. 2013 Aug;302:96-106. doi: 10.1016/j.heares.2013.05.007. Epub 2013 May 25. Hear Res. 2013. PMID: 23711768 Free PMC article.
-
Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease.Front Neurol. 2020 Jul 16;11:689. doi: 10.3389/fneur.2020.00689. eCollection 2020. Front Neurol. 2020. PMID: 32765404 Free PMC article. Review.
-
Hearing loss is not associated with risk of Parkinson's disease: A Mendelian randomization study.Heliyon. 2024 Jun 6;10(11):e32533. doi: 10.1016/j.heliyon.2024.e32533. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38961984 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
